PLEKHA1 Gene: Pleckstrin Homology Domain Containing A1

A gene encoding a protein involved in phosphoinositide signaling and membrane dynamics, with implications in age-related macular degeneration and cancer.

Gene Information Card

Symbol PLEKHA1
Full Name Pleckstrin Homology Domain Containing A1
Gene Type Protein coding
Chromosomal Location 10q26.13
NCBI Gene ID 59338 ncbi.nlm.nih.gov/gene/59338
Ensembl ID ENSG00000107679
UniProt ID Q9HB21
OMIM ID 607772
HGNC ID 19235
Aliases TAPP1, TAPP-1, PH domain-containing family A member 1

Description

PLEKHA1 (Pleckstrin Homology Domain Containing A1) encodes a protein that contains a pleckstrin homology (PH) domain and a C-terminal PDZ-binding motif. The protein, also known as TAPP1, specifically binds phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) and is involved in phosphoinositide signaling, cytoskeletal organization, and membrane trafficking. PLEKHA1 is widely expressed and has been implicated in age-related macular degeneration (AMD) and various cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Age-related Macular Degeneration (AMD) Genetic variants in PLEKHA1 (e.g., rs10490924) are associated with increased risk of AMD, possibly through altered phosphoinositide signaling in retinal pigment epithelium. GWAS studies (NCBI, OMIM #607772)
Breast Cancer PLEKHA1 overexpression may promote cell migration and invasion via PI3K/Akt pathway modulation. Expression profiling (COSMIC, NCBI)
Prostate Cancer Altered PLEKHA1 expression linked to tumor progression and androgen receptor signaling. TCGA data (COSMIC)

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 10.2 Medium
Lung 8.5 Medium
Liver 6.1 Low
Kidney 12.3 Medium
Testis 15.7 High
Retina 14.0 High
Cell Line Expression
Cell Line nTPM Notes
HEK293 11.5 Embryonic kidney cells
HeLa 9.8 Cervical cancer cells
MCF7 13.2 Breast cancer cells
A549 7.4 Lung cancer cells
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
rs10490924 (A69S) Missense ~0.30 (global) Associated with increased AMD risk; may alter PH domain binding affinity.
c.112G>A (p.Gly38Arg) Missense <0.01 Rare variant; functional impact unknown.
c.457C>T (p.Arg153Trp) Missense <0.01 Reported in COSMIC; potential loss of function.
Mutation functional classification

Loss of Function (LOF)

Missense mutations in the PH domain (e.g., p.Arg153Trp) may reduce PtdIns(3,4)P2 binding, impairing membrane recruitment.

Gain of Function (GOF)

Not well characterized; overexpression in cancer may confer gain-of-function effects via enhanced PI3K signaling.

Dominant Negative (DN)

No dominant-negative mutations reported for PLEKHA1.

Pathways

• PI3K/Akt signaling pathway
• Phosphoinositide metabolism
• Fc gamma R-mediated phagocytosis

Protein Summary

The PLEKHA1 protein (TAPP1) is a 329-amino acid adaptor protein that contains a central pleckstrin homology (PH) domain with high specificity for phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2). It localizes to the plasma membrane upon PI3K activation and interacts with proteins such as PDK1 and Akt, modulating cell survival, proliferation, and cytoskeletal dynamics. TAPP1 also contains a C-terminal PDZ-binding motif that mediates interactions with scaffolding proteins. Its expression is highest in testis, retina, and brain, and dysregulation is linked to AMD and cancer.

Related Products

Product name Cat.No. Species Gene ID
PLEKHA1 Knockout HEK293 Cell Line EDJ-KQ14026 Human 59338 Details Get a Quote
PLEKHA1 Knockout A-549 Cell Line EDJ-KQ45189 Human 59338 Details Get a Quote
PLEKHA1 Knockout HCT 116 Cell Line EDJ-KQ45190 Human 59338 Details Get a Quote
PLEKHA1 Knockout HeLa Cell Line EDJ-KQ45191 Human 59338 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: